Transaction #33550 · Form 4 · 0002155916-26-000004
Mirum Pharmaceuticals, Inc. · Stock award · Employee Stock Option (right to buy)
Mirum Pharmaceuticals, Inc. · Transacted October 9, 2026 · Filed October 14, 2026
What does this filing report?
An SEC Form 4 filing for Mirum Pharmaceuticals, Inc. records a stock award involving Employee Stock Option (right to buy) on October 9, 2026. The reported quantity was 40,000. The filing date is October 14, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Mirum Pharmaceuticals, Inc.
- Company CIK
- 0001759425
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 40,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 40,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 14, 2026, 4:06 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Myers Robert Paul ↗
Chief Medical Officer
CIK 0002155916
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 40,000
- Conversion / exercise price
- 86.01
- Exercise date
- Not reported
- Expiration date
- October 8, 2036
Filing footnotes & remarks
- F1
- 1/4th of the shares vest one year after September 21, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
- F2
- Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- F3
- 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of September 21, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.